For example, in AD they may promote Aβ clearance and IL-10/Arg1 expression, while in PD they may inhibit NF-κB and reduce dopaminergic neuron death, and in ALS they could dampen mutant‐protein–induced microglial activation. Here, NFKB1 is linked to amyotrophic lateral sclerosis.